RecruitingNCT06838598

Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical Coherence Tomography


Sponsor

Centre Hospitalier William Morey - Chalon sur Saône

Enrollment

60 participants

Start Date

Jun 3, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

29.3% of bacteremias in intensive care units (ICU) are linked to vascular devices, including 7.7% to arterial catheters, with an influence on both morbility and mortality. It is now accepted that biofilm as a role on bacterial development on inner surface of vascular devices but there is yet a lack of clinical relevant data documenting a causal relation between biofilm formation and bacteremias. The investigators assume that a better structural and microbiological characterization of arterial catheter biofilm in ICU patients could help preventing bacteremias or have a more specific treatment when it appears.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patient or relative informed of the study and having declared their non-objection
  • Patient over 18 years old
  • Patient hospitalized in ICU with an arterial catheter

Exclusion Criteria4

  • Patient unable to express consent
  • Patient whose collection of the arterial catheter is impossible or for whom storage at 4°C is impossible
  • Patient with arterial catheter removed outside the usual procedure of the ICU
  • Patient admitted in ICU with an arterial catheter already in place

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROCT-BIO-KTA cohort

Dynamic full-field optical coherence tomography (D-FF-OCT) analysis of arterial catheter sections before microbiological analysis of catheter biofilm


Locations(2)

CHU Dijon Bourgogne

Dijon, Bourgogne-Franche-Comté, France

CH Macon

Mâcon, Bourgogne-Franche-Comté, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06838598


Related Trials